AngioDynamics Pays $372M for Navilyst

Publicly traded medical device maker AngioDynamics is buying private equity-backed Navilyst Medical in a deal valued at $372 million. Avista Capital Partners acquired Navilyst Medical from Boston Scientific in 2008. Navilyst is a medical device company focused on areas including vascular access, interventional radiology and interventional cardiology.

31 January 2012•10 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles